Filter
4671
Filtered Results: 4671
Text search:
injection
safety
Featured
Recommendations
573
New Publications
1188
Language
Document type
No document type
2295
Guidelines
909
Studies & Reports
676
Manuals
286
Strategic & Response Plan
185
Fact sheets
144
Training Material
79
Situation Updates
39
Infographics
16
Brochures
13
Online Courses
12
Resource Platforms
11
Videos
4
App
2
Countries / Regions
India
207
Global
156
Sierra Leone
137
Kenya
129
Liberia
121
Nigeria
103
South Africa
102
Ethiopia
101
Uganda
87
Western and Central Europe
85
Africa
73
Nepal
62
Tanzania
62
Latin America and the Carribbean
62
Rwanda
60
Malawi
59
Ghana
56
Zambia
53
Bangladesh
53
Syria
47
Philippines
45
Myanmar / Burma
45
Namibia
44
Guinea
42
Russia
41
Congo, Democratic Republic of
36
West and Central Africa
36
South–East Asia Region
32
East and Southern Africa
31
Zimbabwe
29
South Sudan
29
Brazil
29
Middle East and North Africa
29
Ukraine
28
Lesotho
28
Senegal
26
Germany
25
Haiti
23
Eastern Europe
23
Cambodia
22
Burkina Faso
21
Indonesia
21
Eastern Europe and Central Asia
20
Yemen
17
Mozambique
16
Asia
16
USA
15
Pakistan
15
Botswana
15
Eswatini/ Swaziland
14
Cameroon
13
Western Pacific Region
12
Mali
11
Afghanistan
11
Sudan
11
Colombia
10
Angola
10
Vietnam
10
Tajikistan
9
Guinea-Bissau
8
Côte d’Ivoire / Ivory Coast
8
Somalia
8
Jordan
8
Argentina
8
Albania
8
Thailand
7
Peru
7
Iraq
6
Central African Republic
6
Venezuela
6
Laos
6
United Kingdom
6
Spain
6
Niger
5
Lebanon
5
Turkey
5
Papua New Guinea
5
Bolivia
5
Madagascar
5
Bhutan
5
Chad
4
Benin
4
Libya
4
Sri Lanka
4
Chile
4
Paraguay
4
Palestine
4
Timor Leste/ East Timor
4
Georgia
4
Saudi Arabia
3
Togo
3
Gambia
3
China
3
Burundi
3
Southern Africa
3
Moldova
3
Iran
3
Turkmenistan
3
Japan
3
Mauritius
3
Egypt
2
Singapore
2
North Macedonia
2
Serbia
2
Ecuador
2
Qatar
2
Uzbekistan
2
Kyrgyzstan
2
North America
2
Gabon
2
France
2
Tunisia
2
Portugal
2
Morocco
1
Malaysia
1
Dominican Republic
1
Austria
1
Switzerland
1
Croatia
1
El Salvador
1
Greece
1
Guatemala
1
Mexico
1
Nicaragua
1
Fiji
1
Poland
1
Italy
1
Djibouti
1
Congo-Brazzaville
1
Canada
1
Bulgaria
1
Estonia
1
Romania
1
Australia
1
Kazakhstan
1
Jamaica
1
Denmark
1
Belgium
1
Maldives
1
Algeria
1
Azerbaijan
1
French Guyana
1
Israel
1
Bosnia and Herzegovina
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
1641
Clinical Guidelines
488
Key Resources
267
Women & Child Health
256
Public Health
224
Capacity Building
96
Pharmacy & Technologies
74
Toolboxes
COVID-19
749
HIV
379
Ebola
250
TB
245
AMR
245
Rapid Response
194
Caregiver
175
Mental Health
146
Pharmacy
129
Planetary Health
125
NTDs
101
Conflict
81
Refugee
72
Disability
60
Global Health Education
54
Natural Hazards
50
NCDs
48
Cholera
41
Zika
39
Specific Hazards
30
Polio
26
Health Financing Toolbox
19
Social Ethics
3
South Sudan
2
Typhoon
1
Technical Note: Cholera treatment facilities provide inpatient care for cholera patients during outbreaks. Proper case management and isolation of cholera patients is essential to prevent deaths and help control the spread of
the disease. Traditionally, these structures have been referred to as ch...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatit...
It provides guidance on care for use in resource-limited settings or in settings where families with sick young infants do not accept or cannot access referral care, but can be managed in outpatient settings by an appropriately trained health worker. The guideline seeks to provide programmatic guida...
Developed by the HHS Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission—
A Working Group of the Office of AIDS Research Advisory Council (OARAC)
Accessed: 12.02.2020
Module 2
Community Educators and Advocates
July 2017
Module 2: Community educators and advocates. Community educators and advocates are needed to increase awareness about PrEP in their communities. This module provides information on PrEP that should be considered in community-led activities ...
Module 4
Leaders
July 2017
Module 4: Leaders. This module aims to inform and update leaders and decision-makers about PrEP. It provides information on the benefits and limitations of PrEP so that they can consider how PrEP could be effectively implemented in their own settings. It also contai...
Module 6
Pharmacists
July 2017
Module 6: Pharmacists. This module is for pharmacists and people working in pharmacies. It provides information on the medicines used in PrEP, including on storage conditions. It gives suggestions for how pharmacists and pharmacy staff can monitor PrEP adherence...
Module 1q
PrEP users
July 2017
Module 11: PrEP users. This module provides information for people who are interested in taking PrEP to reduce their risk of acquiring HIV and people who are already taking PrEP – to support them in their choice and use of PrEP. This module gives ideas for cou...
7 April 2021
Based on current information, a causal relationship between the vaccine and the occurrence of blood clots with low platelets is considered plausible but is not confirmed.
Available in Englisch, French and Russian
Three classess of tests are now recommended in the latest consolidated guideles on tests for tuberculosis infection. It includes for the first-time a new class of Mycobacterium tuberculosis antigen-based skin tests (TBSTs), and the two existing clas...
HIV & AIDS Treatment in Practice no. 201
Programmatic update
April 2012
Executive Summary
ECDC Technical Report
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 <.... According to the new requirements ‘HTLV-1 antibody testing must be performed for donors living in, or originating from high-prevalence areas or with sexual partners originating from those areas or where the donor’s parents originate from those areas’ and this applies to both donors of non-reproductive tissues and cells and reproductive cells.
ECDC contracted experts from the Institut Pasteur in Paris to systematically review the published evidence on the distribution of HTLV-1 infection prevalence throughout the world and to identify high-prevalence countries and areas.
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 <.... According to the new requirements ‘HTLV-1 antibody testing must be performed for donors living in, or originating from high-prevalence areas or with sexual partners originating from those areas or where the donor’s parents originate from those areas’ and this applies to both donors of non-reproductive tissues and cells and reproductive cells.
ECDC contracted experts from the Institut Pasteur in Paris to systematically review the published evidence on the distribution of HTLV-1 infection prevalence throughout the world and to identify high-prevalence countries and areas.
Module 3
Counsellors
July 2017
Module 3: Counsellors. This module is for staff who counsel people as they consider PrEP or start taking PrEP and support them in coping with side-effects and adherence strategies. Those who counsel PrEP users may be lay, peer or professional counsellors and hea...
